India developed the world’s first intra-nasal COVID vaccine

first intra nasal COVID vaccine – With rising corona cases in China, the Indian government is currently being very cautious and the center is taking all the necessary measures to counter the threat of corona. Corona immunization is once again the Indian government’s main priority. It has introduced the world’s intranasal covid vaccine ‘Incovacc’ from Bharat Biotech to its immunization program as a booster dose. The covid nasal vaccine has been developed by Bharat Biotech in collaboration with Washington University.

Mansukh Mandaviya, the union health minister of the country, declared on 23rd December that the government has given a nod to the inclusion of iNCOVACC in the Covid-19 immunization campaign. On the 24th of this month i.e., Friday, the intranasal Covid-19 vaccination from Bharat Biotech finally made an appearance on the Cowin app. So, to get vaccinated you will need to log in through the Cowin platform and visit the hospital to get your dose. The vaccination will first be available in private hospitals. The cost of the vaccine hasn’t been disclosed yet.

First intra nasal COVID vaccine Overview

COVID Nasal Vaccine 2023
Article title COVID Nasal Vaccine 2023
Category Nasal Vaccine Trial
Grade Health
Trial for Nasal Vaccine 3
Nasal Vaccine Name iNCOVACC
Work as To make a strong Immune System and create Protein in the blood and Nose
Total Vaccination 95.10 Crore
Booster dose Vaccination 22.20 crore

Who Is Eligible For Nasal Vaccine?

For now, the government has declared that the Nasal covid vaccine can be administered as a preventive dosage to people over 18 years of age. Also, people who have taken both or either dose of Covishield or Covaxin or, in some cases, the sputnik v, are the only one who is eligible to get themselves vaccinated by nasal covid dose. The nasal covid vaccine is the first intranasal vaccine to be that is authorized for worldwide usage as a booster dose.

How Does Covid Nasal Vaccine Work?

Like most other viruses coronavirus enters the body through the nose, so nasal vaccination would stimulate the immune system to produce blood and nasal proteins that would help a person to fight infection. The administration of the dosage is very easy. The health care provider would use a small syringe without a needle and spray the vaccine into your nostrils with the help of a dropper. The vaccine requires the administration of four drops in each nostril with a gap of 30 seconds and it would take two weeks for the spray to have an effect on your body.

The trials concluded that covid nasal vaccine did not have any serious side effects. The main side effects are short-term and are those that are seen with all vaccines and include fever, headache, and runny nose. The storage of doses is between 2°C and 8°C temperature which is normal refrigerator temperature. As it doesn’t require massive cold storage infrastructure facilities it would be beneficial for economically weak countries too.

How Effective Is Covid Nasal Vaccine?

The advantage of this vaccine is that it provides very broad-spectrum immunity and also provides local immunity that exists in the nasal cavity itself, thus reducing the rate of infection in those who take it. It also slows down the transfer speed. In this sense, nasal vaccines may be more effective than other vaccines. Nasal vaccination targets immune cells residing in mucosal tissues and membranes, resulting in both systemic and mucosal immunity. The nasal Covid vaccine not only protects against Covid but also prevents the spread of the disease by promoting certain types of immunity that reside primarily in the cells lining the nose and throat.

First intra nasal COVID vaccine
First intra nasal COVID vaccine

Will the risk of corona be averted by the nasal vaccine?

After testing the vaccine, Bharat Biotech claimed that it was highly effective and helped boost immunity against coronavirus. Three trials of the nasal covid vaccine have been conducted and it has shown positive results in all three trials. 175 individuals were included in the first phase trial, and 200 individuals in the second phase trial. After this, there were two trials within the third phase. It has been used in numerous ways on 3,100 people, to begin with, and 875 in the next trial.

In one it was given as a two-dose antibody and in the other as a booster measurement. Bharat Biotech has established large manufacturing plants in many cities including Gujarat, Karnataka, Telangana, and Maharashtra and the vaccine will be given through the nose at a gap of 4 weeks.

You can also read these articles

Summary 

With rising corona cases in China, the Indian government is currently being very cautious and the center is taking all the necessary measures to counter the threat of corona. Corona immunization is once again the Indian government’s main priority. It has introduced the world’s intranasal covid vaccine ‘Incovacc’ from Bharat Biotech to its immunization program as a booster dose. The covid nasal vaccine has been developed by Bharat Biotech in collaboration with Washington University.

From the 24th of December, it is available on the Cowin app. So, to get vaccinated you will need to log in through the Cowin platform and visit the hospital to get your dose. The vaccination will first be available in private hospitals. The cost of the vaccine hasn’t been disclosed yet.

Official Website Click Here
Homepage Click Here

Leave a Comment